COMMUNIQUÉS West-GlobeNewswire

Oxford Immunotec Schedules Second Quarter 2019 Earnings Release and Conference Call for August 6, 2019
18/07/2019
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it plans to [...]
ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019
18/07/2019
Alzheimer’s Association International Conference includes oral session on PMN310 for Alzheimer’s disease and poster presentation on ALS TORONTO and CAMBRIDGE, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- ProMIS [...]
Ascent Industries Announces That Annabeth Rose Joins as Operations Director-Oregon
18/07/2019
VANCOUVER, British Columbia, July 18, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. (CSE: ASNT) ("Ascent") announces Annabeth Rose is joining the new Management Team to lead operations at the Portland, Oregon [...]
Adamis Pharmaceuticals Provides Update on Litigation with kaléo Inc.
18/07/2019
SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today that Adamis and kaléo Inc. agreed to settle all previously announced litigation between the [...]
Sales of VuduMobile assets from ATW TECH
18/07/2019
MONTREAL, July 18, 2019 (GLOBE NEWSWIRE) -- ATW Tech Inc. (the "Company" or "ATW Tech") ( TSX-V: ATW ) today announces the signature of a letter of Intent for the sale of its VuduMobile division to an arm’s length third [...]
Vente des actifs de VuduMobile de ATW TECH
18/07/2019
MONTRÉAL, 18 juill. 2019 (GLOBE NEWSWIRE) -- ATW Tech Inc. (la «» ou « ATW Tech ») ( TSX-V : ATW ) annonce aujourd’hui la signature d’une lettre d’intention visant la vente, sous forme de cession d’actifs, de sa [...]
Spring Bank Announces Research Agreement with The National Institute of Allergy and Infectious Diseases to Evaluate HBV Antisense Oligonucleotide Compounds
18/07/2019
HOPKINTON, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
Rafael Pharmaceuticals Announces Expansion into Israel of Pivotal Phase 3 Trial (AVENGER 500) of CPI-613®️ (devimistat) in Combination with Modified FOLFIRINOX as First-Line Treatment for Patients with Metastatic Pancreatic Cancer
18/07/2019
Cranbury, NJ, July 18, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced the expansion of its Phase [...]
Misonix to Present at the 39th Annual Canaccord Genuity Growth Conference on August 8
18/07/2019
FARMINGDALE, N.Y., July 18, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Parallax Health Sciences Announces Licensing Agreement With HealthPointe Solutions
18/07/2019
Cognitive Artificial Intelligence and Data Analytics Combined with Outcomes Optimization for the Healthcare Market SANTA MONICA, CA, July 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. ( [...]
First Patient Enrolled in Phase 1b/2 Trial of Lixte Biotechnology’s LB-100 in Low or Intermediate-1 Risk Myelodysplastic Syndrome
18/07/2019
EAST SETAUKET, NY, July 18, 2019 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced that the first patient has been enrolled in its Phase 1b/2 study of the safety and therapeutic benefit of [...]
eSolutions Celebrates 20th Anniversary with Rebrand
18/07/2019
OVERLAND PARK, Kan., July 18, 2019 (GLOBE NEWSWIRE) -- Healthcare has changed over the past 20 years – and so has eSolutions. What began in 1999 as a niche clearinghouse business focused on the hospice market has [...]
Nemaura Medical Inc. Appoints Chris Avery as Vice President of Global Business Operations to Support Global Commercial Launch of SugarBEAT®
18/07/2019
Loughborough, England , July 18, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible Continuous [...]
Alphatec Announces Commercial Launch of ALIF IdentiTi™ Porous Titanium Interbody System Implant
18/07/2019
CARLSBAD, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today [...]
MannKind Repays Maturing Debt Obligation; Buys Back Certain Warrants
18/07/2019
WESTLAKE VILLAGE, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced the repayment of outstanding debt by an aggregate amount of approximately $4.0 million and the repurchase [...]
SeaSpine Announces Portfolio Expansion of OsteoStrand™ and OsteoStrand™ Plus Demineralized Bone Fibers
18/07/2019
CARLSBAD, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
MyoKardia Announces HCM Program Updates: Accelerates Timing for Mavacamten Topline Phase 3 Data; Re-acquires U.S. Royalty Rights to HCM Programs from Sanofi
18/07/2019
EXPLORER-HCM Patient Screening Closes Ahead of Schedule – Initial Results Now Anticipated in the Second Quarter of 2020 Royalty Purchase Creates Additional Economic Value for MyoKardia’s Emerging HCM Treatment Portfolio [...]
Organovo Announces Release Date for Fiscal First-Quarter 2020 Financial Results
18/07/2019
SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 8, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal [...]
Genocea to Host Quarterly Corporate Update Conference Call & Webcast on July 25th at 8:30 am ET
18/07/2019
CAMBRIDGE, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, will host its second-quarter 2019 financial [...]

Pages